| scholarly article | Q13442814 |
| P50 | author | Muhammad Usman Mirza | Q37368031 |
| Michiel Vanmeert | Q60732046 | ||
| Matheus Froeyen | Q89040920 | ||
| P2093 | author name string | Amjad Ali | |
| Muhammad Idrees | |||
| Shazia Rafique | |||
| P2860 | cites work | The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase | Q21089768 |
| A systematic screen of FDA-approved drugs for inhibitors of biological threat agents | Q21559667 | ||
| A small-molecule dengue virus entry inhibitor | Q22309806 | ||
| Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein | Q22808780 | ||
| A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model | Q24276422 | ||
| Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus | Q24321691 | ||
| TM-align: a protein structure alignment algorithm based on the TM-score | Q24522708 | ||
| The HHpred interactive server for protein homology detection and structure prediction | Q24530456 | ||
| Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 | ||
| FATCAT: a web server for flexible structure comparison and structure similarity searching | Q24562059 | ||
| I-TASSER: a unified platform for automated protein structure and function prediction | Q24605680 | ||
| BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions | Q36491539 | ||
| Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1 | Q36630055 | ||
| ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. | Q36766916 | ||
| Treatment of Crimean-Congo hemorrhagic fever | Q37039152 | ||
| Homology modeling in drug discovery: current trends and applications | Q37473719 | ||
| De novo drug design | Q37788607 | ||
| An update on crimean congo hemorrhagic Fever | Q37925593 | ||
| Toward in silico structure-based ADMET prediction in drug discovery. | Q37953143 | ||
| Structure-based computational analysis of protein binding sites for function and druggability prediction | Q37971212 | ||
| Molecular mechanisms of action of ribavirin | Q38016839 | ||
| Structural organization of viral RNA-dependent RNA polymerases | Q38099026 | ||
| HCV-targeted antivirals: current status and future challenges | Q38133854 | ||
| Combination of ligand- and structure-based methods in virtual screening | Q38139474 | ||
| Role of computer-aided drug design in modern drug discovery. | Q38553677 | ||
| Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever | Q38565357 | ||
| Development of vaccines against Crimean-Congo haemorrhagic fever virus | Q38688993 | ||
| A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease | Q38840631 | ||
| Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules | Q38896720 | ||
| Structural biology in antiviral drug discovery. | Q38950193 | ||
| Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment | Q24614638 | ||
| 3DLigandSite: predicting ligand-binding sites using similar structures | Q24621635 | ||
| MUSTER: Improving protein sequence profile-profile alignments by using multiple sources of structure information | Q24646301 | ||
| SWISS-MODEL: An automated protein homology-modeling server | Q24672647 | ||
| LOMETS: a local meta-threading-server for protein structure prediction | Q24682449 | ||
| ProFunc: a server for predicting protein function from 3D structure | Q24812633 | ||
| Computational approaches in target identification and drug discovery | Q26746941 | ||
| Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus | Q26750548 | ||
| Recent progress in structure-based anti-influenza drug design | Q26863710 | ||
| Structure-based virtual screening for drug discovery: a problem-centric review | Q27022502 | ||
| Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever | Q27457152 | ||
| Crimean-Congo Hemorrhagic Fever Virus Genomics and Global Diversity | Q27477469 | ||
| De Novo Initiation of RNA Synthesis by the Arterivirus RNA-Dependent RNA Polymerase | Q27481017 | ||
| In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections | Q27481401 | ||
| Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia | Q27485603 | ||
| Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5 | Q27643756 | ||
| Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription | Q27664646 | ||
| Structure, Function, and Evolution of the Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein | Q27671348 | ||
| Conformational Flexibility of the Dengue Virus RNA-Dependent RNA Polymerase Revealed by a Complex with an Inhibitor | Q27676371 | ||
| Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface | Q27679697 | ||
| MOLE 2.0: advanced approach for analysis of biomacromolecular channels | Q27703086 | ||
| Crimean-Congo haemorrhagic fever | Q27860350 | ||
| AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
| Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
| Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase | Q27924228 | ||
| Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins | Q28119724 | ||
| A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases | Q28140411 | ||
| Modeller: generation and refinement of homology-based protein structure models | Q28236254 | ||
| Molecular dynamics and protein function | Q28248486 | ||
| HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment | Q28256122 | ||
| Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure | Q28293030 | ||
| Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo | Q28301982 | ||
| Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere. | Q50596388 | ||
| Comparing ligand interactions with multiple receptors via serial docking. | Q51983899 | ||
| Bunyavirales ribonucleoproteins: the viral replication and transcription machinery. | Q52363184 | ||
| Ensemble-based docking using biased molecular dynamics. | Q53145450 | ||
| Strategies Towards Protease Inhibitors for Emerging Flaviviruses. | Q54557941 | ||
| Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice | Q56395320 | ||
| Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge | Q56395404 | ||
| Ribavirin for treating Crimean Congo haemorrhagic fever | Q56395446 | ||
| Crimean-Congo hemorrhagic fever | Q56505903 | ||
| 2'-Fluoro-2'-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models | Q58550863 | ||
| Perspectives towards antiviral drug discovery against Ebola virus | Q59350906 | ||
| Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis | Q60947009 | ||
| Computational study on the drug resistance mechanism of hepatitis C virus NS5B RNA-dependent RNA polymerase mutants to BMS-791325 by molecular dynamics simulation and binding free energy calculations | Q62075880 | ||
| Ribavirin for treating Crimean Congo haemorrhagic fever. | Q64939069 | ||
| Prediction of drug absorption using multivariate statistics | Q73126791 | ||
| Poliovirus RNA-dependent RNA polymerase (3D(pol)). Divalent cation modulation of primer, template, and nucleotide selection | Q73279890 | ||
| Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches | Q85345616 | ||
| The many roles of computation in drug discovery | Q34307063 | ||
| Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design | Q34371001 | ||
| Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations | Q34531578 | ||
| Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design | Q34624323 | ||
| Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. | Q35116376 | ||
| Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors. | Q35248674 | ||
| A global compendium of human Crimean-Congo haemorrhagic fever virus occurrence | Q35535604 | ||
| Initiation of viral RNA-dependent RNA polymerization | Q35754600 | ||
| Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications | Q35784542 | ||
| Evaluation of Adamantane Derivatives as Inhibitors of Dengue Virus mRNA Cap Methyltransferase by Docking and Molecular Dynamics Simulations | Q36092127 | ||
| Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation | Q36127090 | ||
| Structure and mechanism of DNA polymerases | Q36288580 | ||
| A comparison of viral RNA-dependent RNA polymerases | Q36346703 | ||
| Integrating molecular design resources within modern drug discovery research: the Roche experience | Q36437861 | ||
| Nidovirus transcription: how to make sense...? | Q36475903 | ||
| Ligand docking and structure-based virtual screening in drug discovery | Q28302776 | ||
| The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family | Q28544920 | ||
| Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity | Q29041244 | ||
| Molecular dynamics simulations of Zika virus NS3 helicase: Insights into RNA binding site activity | Q29048113 | ||
| Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase | Q29364910 | ||
| Network medicine: a network-based approach to human disease | Q29547462 | ||
| New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays | Q29615588 | ||
| Relating protein pharmacology by ligand chemistry | Q29617492 | ||
| Identification of four conserved motifs among the RNA-dependent polymerase encoding elements | Q29617964 | ||
| Dengue Virus Non-Structural Protein 5 | Q29994565 | ||
| Applications of computer-aided approaches in the development of hepatitis C antiviral agents | Q30238530 | ||
| High-throughput crystallography for lead discovery in drug design. | Q30331190 | ||
| Utility of homology models in the drug discovery process. | Q30342415 | ||
| Assessment of template-based protein structure predictions in CASP10 | Q30356624 | ||
| Protein structure modeling with MODELLER. | Q30359504 | ||
| Can molecular dynamics simulations provide high-resolution refinement of protein structure? | Q30360592 | ||
| PocketPicker: analysis of ligand binding-sites with shape descriptors. | Q30364721 | ||
| Computational approaches for drug discovery. | Q30366521 | ||
| Using multiple templates to improve quality of homology models in automated homology modeling. | Q30369094 | ||
| Protein model refinement using an optimized physics-based all-atom force field | Q30369943 | ||
| Solvent dramatically affects protein structure refinement. | Q30373863 | ||
| Assessment of template based protein structure predictions in CASP9. | Q30408257 | ||
| Template-based protein structure modeling using the RaptorX web server. | Q30419445 | ||
| T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro | Q30426020 | ||
| Refinement of homology-based protein structures by molecular dynamics simulation techniques | Q30886624 | ||
| MATRAS: A program for protein 3D structure comparison | Q30952001 | ||
| Simple selection criteria for drug-like chemical matter | Q30990966 | ||
| PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data | Q31026348 | ||
| Lessons learnt from assembling screening libraries for drug discovery for neglected diseases | Q33309109 | ||
| Recent advances in computer-aided drug design | Q33443633 | ||
| Molecular docking screens using comparative models of proteins | Q33511631 | ||
| Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function | Q33558533 | ||
| Strategies for development of Dengue virus inhibitors | Q34091777 | ||
| Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
| Nonleadlikeness and leadlikeness in biochemical screening | Q34174693 | ||
| Molecular dynamics simulations of human rhinovirus and an antiviral compound | Q34174708 | ||
| Molecular dynamics-driven drug discovery: leaping forward with confidence | Q39021656 | ||
| Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics | Q39138252 | ||
| Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40. | Q39216411 | ||
| Bunyaviridae RdRps: structure, motifs, and RNA synthesis machinery | Q39248221 | ||
| Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions | Q39452637 | ||
| Mutational analysis of the SDD sequence motif of a PRRSV RNA-dependent RNA polymerase | Q39472908 | ||
| Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase | Q39590614 | ||
| In vitro and in vivo activities of anti-influenza virus compound T-705. | Q39651429 | ||
| Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design | Q40052562 | ||
| Drug repurposing of minocycline against dengue virus infection. | Q40097620 | ||
| Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation | Q40153585 | ||
| Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships | Q40154788 | ||
| Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever | Q40212171 | ||
| Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). | Q40231462 | ||
| Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality | Q40237945 | ||
| Recent advances in hantavirus molecular biology and disease | Q40328927 | ||
| The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain | Q40341178 | ||
| Screening drug-like compounds by docking to homology models: a systematic study. | Q40356909 | ||
| The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising | Q40394302 | ||
| Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus | Q40423159 | ||
| Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience | Q40515398 | ||
| Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment | Q40537825 | ||
| A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus | Q40538104 | ||
| Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate | Q40617493 | ||
| Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. | Q40647542 | ||
| Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases | Q40700712 | ||
| Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection | Q40709251 | ||
| Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase | Q40712125 | ||
| Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins | Q41321617 | ||
| Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter. | Q41720530 | ||
| An Aggregation Advisor for Ligand Discovery. | Q41831853 | ||
| Multiple sequence alignment with user-defined anchor points | Q41842494 | ||
| Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus | Q41917965 | ||
| A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. | Q41929856 | ||
| Structure of influenza A polymerase bound to the viral RNA promoter | Q42181164 | ||
| An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine. | Q42212355 | ||
| Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations | Q42246950 | ||
| A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study | Q42285420 | ||
| Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes | Q42602259 | ||
| admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties | Q42673952 | ||
| SwissTargetPrediction: a web server for target prediction of bioactive small molecules | Q42724602 | ||
| The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen | Q43545743 | ||
| ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. | Q44385818 | ||
| Performance of 3D-database molecular docking studies into homology models | Q44887759 | ||
| Analysis of tombusvirus revertants to identify essential amino acid residues within RNA-dependent RNA polymerase motifs | Q45275892 | ||
| Computational approaches to identifying and characterizing protein binding sites for ligand design | Q45327964 | ||
| http://Mcule.com: a public web service for drug discovery. | Q45788868 | ||
| Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance | Q46523471 | ||
| Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening | Q47558252 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | in silico | Q192572 |
| Orthonairovirus haemorrhagiae | Q1788951 | ||
| P304 | page(s) | 6809 | |
| P577 | publication date | 2019-05-02 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors | |
| P478 | volume | 9 |
| Q99605600 | A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach |
| Q99200481 | Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach |
| Q98894350 | Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches |
| Q99731977 | Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease |
| Q91809201 | In Vitro Antidiabetic, Anti-Obesity and Antioxidant Analysis of Ocimum basilicum Aerial Biomass and in Silico Molecular Docking Simulations with Alpha-Amylase and Lipase Enzymes |
| Q94453408 | Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase |
Search more.